CSI-Sydney: New technologies to treat chronic sinus infection

慢性鼻窦感染（CSI）很普遍，对许多澳大利亚人来说会导致严重的不适和疼痛；但令人惊讶的是，这种疾病没有特效或有效的治疗方法。我们的多学科研究团队和一家澳大利亚健康和医学研究公司（AFT制药）合作开发了一种专门针对鼻窦的新型设备，以及一种能够同时去除鼻腔粘液、分散生物膜和杀死细菌的配方。

Chronic sinus infection (CSI) is prevalent and results in severe discomfort and pain for many Australians; yet amazingly, has no specific cure or effective treatment. Our multi-disciplinary research team and an Australian health and medical research company, (AFT Pharmaceuticals) have partnered to develop a novel device that specifically targets the sinuses and a formulation capable for simultaneously removing mucus, dispersing biofilms and killing bacteria in the nasal cavities.